Proteus Syndrome
📧 Sign up to get email alerts when something new happens for Proteus Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: MK-7075 (Miransertib) in Proteus Syndrome [Phase 2]
A Phase 2 study of Miransertib (MK-7075) for Proteus Syndrome is currently recruiting, sponsored by the National Human Genome Research Insti…
-
CLINICAL_TRIALS trial_result · 2023-03-31Clinical Trial Update: Study of Miransertib (MK-7075) in Participants With PIK3CA-related Overgrowth Spectrum and Proteus Syndrome (MOSAIC) (MK-7075-002) [Phase 1, Phase 2]
Clinical trial update for miransertib in PROS and Proteus Syndrome (MOSAIC) shows the study was terminated; results were posted in 2023.